Description: Theratechnologies is a specialty pharmaceutical company addressing unmet medical needs by bringing to market specialized therapies for people with orphan medical conditions, including those living with HIV.
Home Page: www.theratech.com
THTX Technical Analysis
2015 Peel Street
Montreal,
QC
H3A 1T8
Canada
Phone:
514 336 7800
Officers
| Name | Title |
|---|---|
| Mr. Paul Lévesque | Pres, CEO & Director |
| Mr. Philippe Dubuc M.B.A., MBA | Sr. VP & CFO |
| Dr. Christian Marsolais Ph.D. | Sr. VP & Chief Medical Officer |
| Mr. John Leasure | Global Commercial Officer |
| Ms. Elif McDonald | Sr. Director of Investor Relations |
| Mr. Jocelyn Lafond L.L.M., LL.B. | Gen. Counsel & Corp. Sec. |
| Mr. Denis Boucher B.A., L.L.B. | VP of Communications & Corp. Affairs |
| Hon. Andre Dupras M.Sc. | VP of HR |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: |
| Forward PE: | 55.8659 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 20.1291 |
| Price-to-Sales TTM: | 1.2032 |
| IPO Date: | 2016-01-04 |
| Fiscal Year End: | November |
| Full Time Employees: | 87 |